0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Original Investigation | 
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. 2016;2(5):655-662. doi:10.1001/jamaoncol.2015.5392.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Julie E. Bauman, MD, MPH; Jennifer Grandis, MD
JAMA Oncol. 2016;2(2):178-179. doi:10.1001/jamaoncol.2015.4637.

JAMA Oncology | 
Original Investigation | 
William N. William Jr, MD; Vassiliki Papadimitrakopoulou, MD; J. Jack Lee, PhD; et al.
JAMA Oncol. 2016;2(2):209-216. doi:10.1001/jamaoncol.2015.4364.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Gideon M. Blumenthal, MD; Elizabeth Mansfield, PhD; Richard Pazdur, MD
JAMA Oncol. 2016;2(1):13-14. doi:10.1001/jamaoncol.2015.4503.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
From The JAMA Network |  FREE
Stacey L. Berg, MD; D. Williams Parsons, MD, PhD
JAMA Oncol. 2015;1(7):975-976. doi:10.1001/jamaoncol.2015.1173.

JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;313(20):2015. doi:10.1001/jama.2015.5173.

JAMA Psychiatry | 
Original Investigation |  FREE
David W. Oslin, MD; Shirley H. Leong, PhD; Kevin G. Lynch, PhD; et al.
JAMA Psychiatry. 2015;72(5):430-437. doi:10.1001/jamapsychiatry.2014.3053.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
Fan Liao, PhD; David M. Holtzman, MD
JAMA Neurol. 2014;71(12):1475-1476. doi:10.1001/jamaneurol.2014.2802.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncology
Editorial  | 
Oral Cancer Chemoprevention—The End of EPOC, the Beginning of an Epoch of Molecular Selection
Julie E. Bauman, MD, MPH; Jennifer Grandis, MD
JAMA Oncology
Original Investigation  | 
Erlotinib and the Risk of Oral Cancer The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
William N. William Jr, MD; Vassiliki Papadimitrakopoulou, MD; J. Jack Lee, PhD; et al.
JAMA Oncology
Editorial  | 
Trastuzumab and Cardiac Outcomes in Breast Cancer A Story We Know by Heart?
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD